News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Karine Tawagi: New U.S. FDA approval for Enzalutamide in BCR prostate cancer
Photo taken from Karine Tawagi/Twitter
Nov 19, 2023, 16:51

Karine Tawagi: New U.S. FDA approval for Enzalutamide in BCR prostate cancer

Karine Tawagi, Assistant Professor of Clinical Medicine and Associate Program Director at the University of Illinois, Chicago, recently shared on X/Twitter:

“New U.S. FDA approval for Enzalutamide in BCR prostate cancer:
– Patients with BCR post-prostatectomy and/or RT, PSA DBT <=9 months, not candidate for salvage RT.
– MFS at 5 years: 87.3% for enzalutamide/ADT vs 80.0% for Enzalutamide alone vs 71.4% for ADT alone.
– OS immature
– AEs: hot flash, MSK, fatigue.”

Karine Tawagi: New U.S. FDA approval for Enzalutamide in BCR prostate cancer

Source: Karine Tawagi/Twitter

cancer Enzalutamide Karine Tawagi OncoDaily Oncology prostate cancer
Special Coverage
Science
Mar 22, 2025, 09:11
Myeloma Paper of the Day, March 22nd, suggested by Robert Orlowski
Blog
Mar 22, 2025, 09:00
Andrea Anampa-Guzmán: Fantastic time at the ASCO AIOM Clinical Research Course
Blog
Mar 22, 2025, 08:43
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Blog
Mar 22, 2025, 08:34
Registration open for the 8th "Combinations and Sequences in therapy" conference
Blog
Mar 22, 2025, 08:02
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
Science
Mar 22, 2025, 07:56
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab
Blog
Mar 22, 2025, 07:49
UICC joined the Commonwealth Secretariat and the Lancet Oncology Commission in London
Blog
Mar 22, 2025, 07:42
President of Cairo University visited the Breast Cancer Hospital (NCI - New Cairo)
Blog
Mar 22, 2025, 07:31
Istvan Petak: We have officially launched BRECISE in Madrid
Science
Mar 22, 2025, 07:26
Elvina Almuradova: Cemiplimab monotherapy vs chemotherapy as a first-line treatment with advanced NSCLC with PD-L1 expression
Blog
Mar 22, 2025, 07:23
Reducing disparities in cancer prevention, screening, and access to treatment - SPCC
Science
Mar 22, 2025, 07:12
Jennifer Bires: Fertility Preservation in People with Cancer